These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9262130)

  • 1. Effects of MRI abnormalities on WAIS-R performance in solvent abusers.
    Yamanouchi N; Okada S; Kodama K; Sakamoto T; Sekine H; Hirai S; Murakami A; Komatsu N; Sato T
    Acta Neurol Scand; 1997 Jul; 96(1):34-9. PubMed ID: 9262130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse.
    Rosenberg NL; Grigsby J; Dreisbach J; Busenbark D; Grigsby P
    J Toxicol Clin Toxicol; 2002; 40(1):21-34. PubMed ID: 11990201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic solvent abuse. 1. Cognitive sequelae.
    Zur J; Yule W
    Child Care Health Dev; 1990; 16(1):1-20. PubMed ID: 2311197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the WAIS-R Verbal-Performance IQ difference and intersubtest scatter to traumatic brain injury. Wechsler Adult Intelligence Scale-Revised.
    Kraiuhin C; Shores EA; Roberts C
    Brain Inj; 1996 Sep; 10(9):677-85. PubMed ID: 8853870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study.
    Garde E; Mortensen EL; Krabbe K; Rostrup E; Larsson HB
    Lancet; 2000 Aug; 356(9230):628-34. PubMed ID: 10968435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter changes caused by chronic solvent abuse.
    Yamanouchi N; Okada S; Kodama K; Hirai S; Sekine H; Murakami A; Komatsu N; Sakamoto T; Sato T
    AJNR Am J Neuroradiol; 1995 Sep; 16(8):1643-9. PubMed ID: 7502969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of neuroimaging abnormalities in solvent abuse and their clinical correlation.
    Caldemeyer KS; Armstrong SW; George KK; Moran CC; Pascuzzi RM
    J Neuroimaging; 1996 Jul; 6(3):167-73. PubMed ID: 8704292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pattern of solvent consumption and neuropsychological damage associated with their use].
    Sosa R; Ortiz A; Caudillo C
    Salud Publica Mex; 1989; 31(5):634-41. PubMed ID: 2609225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wechsler Adult Intelligence Scale-III inter-subtest scatter: a comparison of brain-damaged patients and normal controls.
    Ryan JJ; Tree HA; Morris J; Gontkovsky ST
    J Clin Psychol; 2006 Oct; 62(10):1319-26. PubMed ID: 16897733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging in drug and substance abuse part II: opioids and solvents.
    Borne J; Riascos R; Cuellar H; Vargas D; Rojas R
    Top Magn Reson Imaging; 2005 Jun; 16(3):239-45. PubMed ID: 16340648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory and motor skill components of the WAIS-III Digit Symbol-Coding subtest.
    Kreiner DS; Ryan JJ
    Clin Neuropsychol; 2001 Feb; 15(1):109-13. PubMed ID: 11778571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of the effect of donepezil hydrochloride on cognitive function in patients with dementia of Alzheimer's type using WAIS-R].
    Ueki A; Shinjo H; Shimode H; Nakajima T; Morita Y
    No To Shinkei; 2004 Jan; 56(1):42-8. PubMed ID: 15024828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Callosal atrophy in patients with lacunar infarction and extensive leukoaraiosis. An indicator of cognitive impairment.
    Yamauchi H; Fukuyama H; Ogawa M; Ouchi Y; Kimura J
    Stroke; 1994 Sep; 25(9):1788-93. PubMed ID: 8073459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial MR findings in chronic toluene abuse by inhalation.
    Aydin K; Sencer S; Demir T; Ogel K; Tunaci A; Minareci O
    AJNR Am J Neuroradiol; 2002 Aug; 23(7):1173-9. PubMed ID: 12169477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wechsler adult intelligence scale-revised in the evaluation of anterior temporal lobectomy candidates.
    Hermann BP; Gold J; Pusakulich R; Wyler AR; Randolph C; Rankin G; Hoy W
    Epilepsia; 1995 May; 36(5):480-7. PubMed ID: 7614926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WAIS-III and major depression: absence of VIQ/PIQ differences.
    Gorlyn M; Keilp JG; Oquendo MA; Burke AK; Sackeim HA; John Mann J
    J Clin Exp Neuropsychol; 2006 Oct; 28(7):1145-57. PubMed ID: 16840241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.
    Ponjaert-Kristoffersen I; Bonduelle M; Barnes J; Nekkebroeck J; Loft A; Wennerholm UB; Tarlatzis BC; Peters C; Hagberg BS; Berner A; Sutcliffe AG
    Pediatrics; 2005 Mar; 115(3):e283-9. PubMed ID: 15741353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Ward seven-subtest WAIS-III short form in a neuropsychological population.
    Pilgrim BM; Meyers JE; Bayless J; Whetstone MM
    Appl Neuropsychol; 1999; 6(4):243-6. PubMed ID: 10635439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On substituting the WAIS-R for the WAIS in neuropsychological assessment: a caution for clinicians.
    Ryan JJ; Rosenberg SJ; Prifitera A
    J Psychol; 1983 Sep; 115(1st Half):131-4. PubMed ID: 6631769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the Wechsler abbreviated scale of intelligence and other very short forms of estimating intellectual functioning.
    Axelrod BN
    Assessment; 2002 Mar; 9(1):17-23. PubMed ID: 11911230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.